Newsroom

Put your finger on the pulse of the healthcare industry.

Contact

Get in touch Please complete the form below, and a representative will be in touch as soon as possible. Departments […]

Sponsorship Applications

At Innovative Medicines Canada, we offer sponsorship opportunities to facilitate research, generate awareness, create educational programs, and improve access to innovative medicines.

Twitter Feed

At our most recent policy summit, we brought together key stakeholders in Canada’s private #health insurance industry to discuss the future of the sector, emphasizing the need to innovate to keep offering value of Canadians.
Read it here:
https://www.benefitscanada.com/benefits/health-benefits/sounding-board-private-health-insurance-industry-needs-to-innovate-to-keep-offering-value-to-canadians/

We applaud @ONgov ongoing work towards strengthening the #LifeSciences sector and we’re committed to further collaboration with stakeholders. We look forward to seeing this strategy come to life!

IMC welcomes Ontario’s re-tabled 2022 Budget and the government’s investments in #lifesciences and innovation. We look forward to continuing to work with @ONgov to ensure Ontarians, and all Canadians, get timely access to medicines. #onpoli

✨NEW EDITORIAL✨

Check out our recent post from @pcfralick at @innovativemeds as part of our “Building Resilience During International Crisis” editorial series.

Read the full article here: https://sciencepolicy.ca/posts/waiving-ip-rights-for-covid-19-vaccines-sends-the-wrong-message-to-innovators/

#IPRights #Covid19 #InnovationPolicy

In a recent article in @sciencepolicy, IMC President @pcfralick cautions that “IP waivers undervalue the very science, innovation and collaboration needed to prepare for tomorrow’s crises.” Read the full article: https://sciencepolicy.ca/posts/waiving-ip-rights-for-covid-19-vaccines-sends-the-wrong-message-to-innovators/
#TRIPSWaiver

Le #cancer du poumon est le cancer le plus fréquemment diagnostiqué dans le monde et, malheureusement, il présente l’un des pires taux de survie à cinq ans de tous les cancers, soit 19 % seulement, selon une nouvelle étude du @ConfBoardofCda. ESP : https://www.conferenceboard.ca/focus-areas/health/demain-ne-peut-attendre

JOIN MEDIA LIST

Be the first to get our news

Sign up to our newsletter to get our latest news and updates.

resources

Discover. Learn.
Understand.

Informative content to keep you up to date on the most pressing issues facing our industry.